Reliq Health Technologies and Hucu.ai Announce an Agreement to Enhance Communication for Virtual Care – PR.com

Chicago,
IL,
February
06,
2025
–(PR.com)– Reliq
Health
Technologies
and
Hucu.ai
Announce
an
Agreement
to
Enhance
Communication
for
Virtual
Care;
Expected
to
Add
Over
10,000
New
Patients.

Reliq
Health
Technologies
Inc.
(NEX:RHT.H
or
OTC:RQHTF
or
WKN:A2AJTB)
(“Reliq”
or
the
“Company”),
a
growing
global
healthcare
technology
company
that
develops
innovative
Virtual
Care
solutions
for
the
multi-billion
dollar
Healthcare
market,
is
pleased
to
announce
that
it
has
signed
a
contract
with
Hucu.ai
to
embed
Hucu.ai’s
intelligent
communication
capabilities
into
Reliq’s
solutions.

Hucu
is
the
most
advanced,
patient-centered
HIPAA
compliant
intelligent
communication
solution
in
healthcare,
designed
specifically
for
the
delivery
of
care
where
the
care
team
is
decentralized,
diverse,
and
dynamic
for
each
patient.
Hucu
is
currently
in
use
by
over
700
organizations
around
the
country
and
is
particularly
valuable
in
post-acute
and
sub-acute
care
segments
of
healthcare,
value-based
care
(VBC,
ACOs),
home-care,
Area
Agencies
in
Aging
(AAAs).
The
agreement
is
expected
to
add
over
10,000
new
patients
to
both
companies’
platforms
by
the
end
of
2026.

“We
are
very
pleased
to
be
adding
Hucu’s
communication
solution
to
our
virtual
care
solution
to
speed
and
streamline
communication
in
real
time
between
Reliq’s
care
and
implementation
team
members
and
their
patients,
as
well
as
family
members,
other
clients,
and
partner
physicians
all
in
a
single
secure
platform,”
said
Chris
Shields,
CEO
at
Reliq
Health
Technologies,
Inc.

The
integrated
solution
is
expected
to
build-upon
the
advantages
the
Reliq
solution
already
delivers
in
improving
patient
outcomes
through
even
more
timely
interventions
and
further
reducing
provider
burnout
while
improving
the
financial
bottom
line
for
those
organizations
caring
for
medicare
beneficiaries.

In
addition
to
Reliq’s
use
of
Hucu
in
delivery
of
its
services,
both
organizations
will
collaborate
on
the
introduction
of
one-another’s
solutions
to
their
existing
client
bases
and
will
work
jointly
to
introduce
an
integrated
solution
to
new
clients.

“We’re
very
excited
about
this
partnership,”
said
Asif
Khan,
CEO
of
Hucu.ai.
He
continued,
“As
we
see
more
healthcare
move
outside
of
acute
settings
like
hospitals,
the
challenge
becomes
one
of
not
only
data
sharing,
but
timely
communication.
This
is
why
we
built
Hucu
to
specifically
address
those
challenges.
And
partnering
with
Reliq,
a
leader
in
supporting
patients
through
Remote
Therapeutic
Monitoring,
we
expect
to
see
an
even
greater
level
of
positive
transformation
as
to
what’s
possible.”

About
Reliq
Health
Reliq
Health
Technologies
is
a
rapidly
growing
global
healthcare
technology
company
that
specializes
in
developing
innovative
Virtual
Care
solutions
for
the
multi-billion
dollar
Healthcare
market.
Reliq’s
powerful
iUGO
Care
platform
supports
care
coordination
and
community-based
virtual
healthcare.
iUGO
Care
allows
complex
patients
to
receive
high
quality
care
at
home,
improving
health
outcomes,
enhancing
quality
of
life
for
patients
and
families
and
reducing
the
cost
of
care
delivery.
iUGO
Care
provides
real-time
access
to
remote
patient
monitoring
data,
allowing
for
timely
interventions
by
the
care
team
to
prevent
costly
hospital
readmissions
and
ER
visits.
Reliq
Health
Technologies
trades
on
the
NEX
under
the
symbol
RHT,
on
the
OTC
as
RQHTF
and
on
the
Frankfurt
Stock
Exchange
under
the
WKN:
A2AJTB.

About
Hucu.AI
Hucu.AI
is
the
leader
in
transforming
care
delivery
in
sub-acute
and
post-acute
care
environments
such
as
Providers/NP
Groups,
Skilled
Nursing,
Assisted
&
Independent
Living,
Home
Care,
Hospice,
Palliative
care.
It
is
also
growing
in
use
among
ACOs,
CCRs,
and
AAAs
where
outcomes
are
directly
impacted
by
the
efficiency
by
which
independent
organizations
and
teams
of
MDs,
NPs,
RNs,
Care
Coordinators,
and
others
collaborate
in
support
of
a
patient.
Hucu.ai
is
based
in
Chicago,
and
is
privately
held.
To
learn
more,
visit
https://Hucu.ai.

For
further
information
please
contact:

Company
Contact
Investor
Relations
at
ir@reliqhealthus.com

Neither
the
NEX
nor
its
Regulation
Services
Provider
(as
that
term
is
defined
in
the
policies
of
the
NEX)
accepts
responsibility
for
the
adequacy
or
accuracy
of
this
release.

Cautionary
Statements
Regarding
Forward
Looking
Information
Certain
statements
in
this
press
release
constitute
forward-looking
statements,
within
the
meaning
of
applicable
securities
laws.
All
statements
that
are
not
historical
facts,
including
without
limitation,
statements
regarding
future
estimates,
plans,
programs,
forecasts,
projections,
objectives,
assumptions,
expectations
or
beliefs
of
future
performance,
are
“forward-looking
statements.”

We
caution
you
that
such
“forward-looking
statements”
involve
known
and
unknown
risks
and
uncertainties
that
could
cause
actual
and
future
events
to
differ
materially
from
those
anticipated
in
such
statements.

Forward-looking
statements
include,
but
are
not
limited
to,
statements
with
respect
to
commercial
operations,
including
technology
development,
anticipated
revenues,
projected
size
of
market,
and
other
information
that
is
based
on
forecasts
of
future
results,
estimates
of
amounts
not
yet
determinable
and
assumptions
of
management.

Reliq
Health
Technologies
Inc.
(the
“Company”)
does
not
intend
and
does
not
assume
any
obligation,
to
update
these
forward-looking
statements
except
as
required
by
law.
These
forward-looking
statements
involve
risks
and
uncertainties
relating
to,
among
other
things,
technology
development
and
marketing
activities,
the
Company’s
historical
experience
with
technology
development,
uninsured
risks.
Actual
results
may
differ
materially
from
those
expressed
or
implied
by
such
forward-looking
statements.

Source:
Reliq
Health
Technologies
Inc.